rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2000-3-24
|
pubmed:abstractText |
Fractionated total-body irradiation (HTBI) is considered to induce less toxicity to normal tissues and probably has the same efficacy as single-dose total-body irradiation (STBI) in patients with acute myeloid leukemia. We decided to determine whether this concept can be applied to a large number of patients with various hematologic malignancies using two dissimilar fractionation schedules.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:BaumeDD,
pubmed-author:BeaudreAA,
pubmed-author:BenhamouEE,
pubmed-author:BouaouinaNN,
pubmed-author:BourhisJ HJH,
pubmed-author:BridierAA,
pubmed-author:BriotEE,
pubmed-author:CossetJ MJM,
pubmed-author:DhermainFF,
pubmed-author:GanansiaVV,
pubmed-author:GirinskyTT,
pubmed-author:Guillot-VallsDD,
pubmed-author:LuboinskiMM,
pubmed-author:NagoHH,
pubmed-author:PerezAA,
pubmed-author:SocieGG
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
981-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10694547-Adolescent,
pubmed-meshheading:10694547-Adult,
pubmed-meshheading:10694547-Dose Fractionation,
pubmed-meshheading:10694547-Female,
pubmed-meshheading:10694547-Hematologic Neoplasms,
pubmed-meshheading:10694547-Humans,
pubmed-meshheading:10694547-Male,
pubmed-meshheading:10694547-Multivariate Analysis,
pubmed-meshheading:10694547-Radiation Dosage,
pubmed-meshheading:10694547-Survival Analysis,
pubmed-meshheading:10694547-Whole-Body Irradiation
|
pubmed:year |
2000
|
pubmed:articleTitle |
Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies.
|
pubmed:affiliation |
Departments of Radiation Oncology, Biostatistics and Epidemiology, and Medicine, Institut Gustave Roussy, Villejuif, France. girinski@igr.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|